Reid Laurence — SEC Form 4 filings

SEC reporting owner CIK 1492749. 5 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-11-26 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Metagenomi Therapeutics, Inc. (MGX)Director32 legs · 20,000 sh · $23,4012
KalVista Pharmaceuticals, Inc. (KALV)Director22

Form 4 filings — Reid Laurence

FiledFormIssuerReported transactionsSource
2026-09-114Metagenomi Therapeutics, Inc. (MGX)Purchase (P): 19,883 @ $1.17 · Purchase (P): 117 @ $1.18EDGAR
2026-06-114KalVista Pharmaceuticals, Inc. (KALV)Disposition to issuer (D): 17,000 (derivative)EDGAR
2026-06-114Metagenomi Therapeutics, Inc. (MGX)Grant/award (A): 17,400 (derivative) @ $0EDGAR
2025-09-024Metagenomi, Inc. (MGX)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2024-11-264KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 17,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1492749 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →